TY - JOUR T1 - Segmentation and shielding of the most vulnerable members of the population as elements of an exit strategy from COVID-19 lockdown JF - medRxiv DO - 10.1101/2020.05.04.20090597 SP - 2020.05.04.20090597 AU - Bram A.D. van Bunnik AU - Alex L.K. Morgan AU - Paul R. Bessell AU - Giles Calder-Gerver AU - Feifei Zhang AU - Samuel Haynes AU - Jordan Ashworth AU - Shengyuan Zhao AU - Nicola Rose Cave AU - Meghan R. Perry AU - Hannah C. Lepper AU - Lu Lu AU - Paul Kellam AU - Aziz Sheikh AU - Graham F. Medley AU - Mark E.J. Woolhouse Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/08/2020.05.04.20090597.abstract N2 - In this study we demonstrate that the adoption of a segmenting and shielding (S&S) strategy could increase scope to partially exit COVID-19 lockdown while limiting the risk of an overwhelming second wave of infection.The S&S strategy has an antecedent in the “cocooning” of infants by immunisation of close family members (Forsyth et al., 2015), and forms a pillar of infection, prevention and control (IPC) strategies (RCN, 2017). We are unaware of it being proposed as a major public health initiative previously.We illustrate the S&S strategy using a mathematical model that segments the vulnerable population and their closest contacts, the “shielders”. We explore the effects on the epidemic curve of a gradual ramping up of protection for the vulnerable population and a gradual ramping down of restrictions on the non-vulnerable population over a period of 12 weeks after lockdown.The most important determinants of outcome are: i) post-lockdown transmission rates within the general population segment and between the general and vulnerable segments; ii) the fraction of the population in the vulnerable and shielder segments; iii) adherence with need to be protected; and iv) the extent to which population immunity builds up in all segments.We explored the effects of extending the duration of lockdown and faster or slower transition to post-lockdown conditions and, most importantly, the trade-off between increased protection of the vulnerable segment and fewer restrictions on the general population.We illustrate how the potential for the relaxation of restrictions interacts with specific policy objectives. We show that the range of options for relaxation in the general population can be increased by maintaining restrictions on the shielder segment and by intensive routine screening of shielders.We find that the outcome of any future policy is strongly influenced by the contact matrix between segments and the relationships between physical distancing measures and transmission rates. These relationships are difficult to quantify so close monitoring of the epidemic would be essential during and after the exit from lockdown.More generally, S&S has potential applications for any infectious disease for which there are defined proportions of the population who cannot be treated or who are at risk of severe outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur work is supported by the European Union (ref. 874735), Novo Nordisk Foundation (ref. NNF16OC0021856) and the Wellcome Trust (ref. 218492/Z/19/Z).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in the github repository at http://www.github.com/bvbunnik/COVID-19-enhanced-shielding. http://www.github.com/bvbunnik/COVID-19-enhanced-shielding ER -